Breast papillary lesions diagnosed and treated using ultrasound-guided vacuum-assisted excision

• Published in: BMC surgery Vol. 20; no. 1; p. 204
• Main Authors: Li, Xiaohui, Gao, Hua, Xu, Minling, Wu, Yang, Gao, Dezong
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 15.09.2020; BioMed Central; BMC
• Subjects: Asymptomatic; Biopsy; Breast; Breast - diagnostic imaging; Breast - surgery; Breast Neoplasms - diagnostic imaging; Breast Neoplasms - surgery; Diagnosis; Health aspects; Humans; Hyperplasia; Lesions; Medical imaging; Neoplasm Recurrence, Local - diagnostic imaging; Neoplasm Recurrence, Local - surgery; Papillary lesions; Papilloma; Patients; Retrospective Studies; Skin; Statistical analysis; Surgery; Treatment; Ultrasonic imaging; Ultrasonography; Ultrasonography, Interventional; Ultrasound; Ultrasound imaging; Vacuum; VAE; United States > US; Papillary lesions; Breast; Treatment; VAE
• ISSN: 1471-2482; 1471-2482
• DOI: 10.1186/s12893-020-00869-7

The management of papillary lesions of the breast remains controversial, and thus, we assessed the value of vacuum-assisted excision (VAE)-guided ultrasound in the diagnosis and treatment of breast papillary lesions. We retrospectively reviewed the data of 108 patients with papillary lesions diagnosed using VAE between August 2014 and January 2019. Cases without postoperative breast imaging in the follow-up were excluded, and 85 cases were eligible for the study. The follow-up period ranged from 6 to 53 months, with 38 months on average. All the papillary lesions were located away from the skin or nipple with a size less than or equal to 30 mm, and the lesions categorized as C2-4b were completely excised using VAE. All VAEs were performed using an 8-gauge vacuum-assisted biopsy needle under the guidance of ultrasound using a 10 MHz linear probe. Most patients with breast papillary lesions were asymptomatic (56.5%), and when the size of the breast papillary lesion was more than 20 mm on ultrasound imaging, atypical hyperplasia may have been concomitant. Breast lesions might have been pathologically diagnosed as papilloma after biopsy when they were categorized as BI-RADS 4a on ultrasound images. The rate of underestimation was 7.7% in papillary lesions diagnosed with VAE, and the recurrence rate of papilloma after VAE was low. Breast papilloma was a common lesion on ultrasonographic screening, and VAE was applicable for completely excising small papillomas, even papillomas with atypical hyperplasia, to obtain an accurate diagnosis with a low rate of underestimation and recurrence. We believe that papilloma diagnosed by VAE might not require immediate excision, and imaging follow-up may be safe for at least 3 years.